CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Sentec LuMon Device (EIT system) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06609135
NCT06609135N/ACompleted

Relationship Between Electrical Impedance Tomography (EIT) Measurements and Parameters of Respiratory Status in Very Preterm Infants: An Observational Cohort Study

Lawrence Rhein·interventional·Posted Sep 24, 2024·Updated Oct 9, 2025

In Brief

A clinical study evaluating Sentec LuMon Device (EIT system) and Sentec Digital Monitoring System (transcutaneous CO2 monitor) for Chronic Lung Disease of Prematurity and 2 related conditions. Completed, enrolled 20 participants across 1 site.

Detailed Summary

Electrical Impedance Tomography (EIT) is a non-invasive imaging technique that can measure lung function in real time. This study will follow premature infants to see if EIT can help predict which infants will be successful in weaning off respiratory support by 32-33 weeks gestational age. If successful, EIT could be used to develop new guidelines for respiratory support in premature infants.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
202420252026
First PostedSep 24, 2024
Enrollment StartNov 4, 2023
Primary CompletionAug 31, 2024
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 1.8 years ago

Interventions

Sentec LuMon Device (EIT system)device

Sentec EIT belts will be placed on infants up to once daily from consent through NICU discharge.

Sentec Digital Monitoring System (transcutaneous CO2 monitor)device

Sentec transcutaneous CO2 monitors will be placed on infants concurrently with EIT belts.